Growth Metrics

Organogenesis Holdings (ORGO) Total Non-Current Liabilities (2017 - 2025)

Organogenesis Holdings has reported Total Non-Current Liabilities over the past 9 years, most recently at $163.6 million for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $163.6 million for Q4 2025, up 46.51% from a year ago — trailing twelve months through Dec 2025 was $163.6 million (up 46.51% YoY), and the annual figure for FY2025 was $163.6 million, up 46.51%.
  • Total Non-Current Liabilities for Q4 2025 was $163.6 million at Organogenesis Holdings, up from $121.3 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for ORGO hit a ceiling of $202.0 million in Q2 2022 and a floor of $96.9 million in Q2 2025.
  • Median Total Non-Current Liabilities over the past 5 years was $178.8 million (2024), compared with a mean of $166.7 million.
  • Peak annual rise in Total Non-Current Liabilities hit 46.51% in 2025, while the deepest fall reached 45.69% in 2025.
  • Organogenesis Holdings' Total Non-Current Liabilities stood at $200.4 million in 2021, then dropped by 8.88% to $182.6 million in 2022, then dropped by 1.32% to $180.1 million in 2023, then plummeted by 38.01% to $111.7 million in 2024, then soared by 46.51% to $163.6 million in 2025.
  • The last three reported values for Total Non-Current Liabilities were $163.6 million (Q4 2025), $121.3 million (Q3 2025), and $96.9 million (Q2 2025) per Business Quant data.